Physician profile
Cu N Phan
NPI 1417003633
$4,574.09
in general payments reported to CMS, 2019-2025
26 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,139 · 2020: $131 · 2021: $286 · 2022: $1,887 · 2023: $410 · 2024: $324 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,561.97 | 2022 | |
| Procept Biorobotics Corporation | $1,337.00 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Hollister Incorporated | $228.69 | 2019-2024 | Vapro |
| Sumitomo Pharma America, INC. | $202.35 | 2023-2025 | Orgovyx, Gemtesa |
| Abc Home Medical Supply, INC. | $129.40 | 2022-2025 | |
| 180 Medical, INC. | $128.85 | 2020-2021 | |
| Laborie Medical Technologies Corp. | $128.18 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Antares Pharma, INC. | $117.86 | 2022 | |
| Coloplast Corp | $96.60 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $83.85 | 2023-2025 | Pylarify |
| Janssen Biotech, INC. | $76.86 | 2025 | Erleada |
| Myovant Sciences INC. | $67.82 | 2021-2022 | |
| Tolmar, INC. | $61.77 | 2023 | |
| Pfizer INC. | $57.16 | 2019-2022 | |
| Olympus America INC. | $32.44 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $31.70 | 2022 | |
| Merck Sharp & Dohme LLC | $30.84 | 2019 | |
| Ferring Pharmaceuticals INC. | $29.90 | 2024 | Adstiladrin |
| Immunitybio, INC. | $28.03 | 2024 | |
| Bard Access Systems, INC. | $26.96 | 2019 | |
| Urovant Sciences INC | $23.04 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $21.14 | 2019 | |
| Calyxo, INC. | $19.93 | 2024 | Cvac Aspiration System |
| Caris Mpi, INC. | $18.37 | 2025 | Mi Cancer Seek |
| Srs Medical Systems, INC. | $17.66 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $15.72 | 2023 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cu Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.